Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 2685-2690, November 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chernozemski, I. N.
Right arrow Articles by Warwick, G. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chernozemski, I. N.
Right arrow Articles by Warwick, G. P.

Liver Regeneration and Induction of Hepatomas in B6AF1 Mice by Urethan1

I. N. Chernozemski2 and G. P. Warwick3

Chester Beatty Research Institute, Institute of Cancer Research, Royal Cancer Hospital, Fulham Road, London S. W. 3, England

The pattern of regeneration and cell proliferation was studied in liver remnants of B6AF1 hybrid mice during the first 85 hr following partial hepatectomy. On the basis of the estimated timing of DNA synthesis and mitoses, male and female adult mice were inoculated once with urethan, 1 mg/g body weight, at the following times after partial hepatectomy: 4 to 5 hr, i.e., at an early prereplicative period; 17 to 18 hr, during a late prereplicative period; 31 to 33 hr, shortly before the onset of extensive DNA duplication; and 46 hr, before the peak of mitoses.

The hepatoma incidence showed a clear-cut relationship between the timing of urethan treatment in relation to prior hepatectomy. After 13 months, 10, 68, 42, and 77% of the male animals bore at least one hepatoma, compared with 3.3% among untreated males, 6% in those treated only with urethan, and 19.4% following hepatectomy alone. Hepatic tumors were rare in the females. In urethan-treated mice, body weight was reduced by up to 50% of that of controls.

1 This study was supported by a grant from the Medical Research Council and British Empire Cancer Campaign for Research.

2 This work was carried out during a Research Fellowship of the International Agency for Research on Cancer, Lyon, France, while on leave from Oncological Research Institute, Sofia 56, Bulgaria.

3 To whom reprint requests should be addressed at Chester Beatty Research Institute.

Received 3/27/70. Accepted 7/14/70.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.